Physician Assistant · Dallas, TX
NPI
1770706343
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1801 Inwood Rd Suite 6.102
Dallas, TX, 75390
Phone (214) 645-0595
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
378 services
Medicare patients, 2024
186
Average age 71
Drug cost, 2024
$6.4M
1,177 prescriptions
Company payments, 2025
$5,966
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura E Pontes was code 99214 (office e&m - established), 182 times for 134 patients. In total Laura E Pontes billed 378 services in 8 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 182 | 134 | $78.07 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 105 | 83 | $10.27 | $1,079 |
| 99213 Office E&M - Established | Office | 46 | 42 | $54.98 | $2,529 |
| 99215 Office E&M - Established | Office | 28 | 25 | $108.56 | $3,040 |
By year: 2022 $22K for 295 services; 2023 $18K for 234 services; 2024 $23K for 378 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura E Pontes prescribed most often to Medicare patients was Stelara (Ustekinumab), with 165 prescriptions and refills. In total Laura E Pontes wrote 1,177 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 165 | 204 | 23 | $4.4M |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 82 | 96 | 29 | $3,512 |
| Dicyclomine Hcl Generic | 80 | 108 | 23 | $2,179 |
| Pantoprazole Sodium Generic | 72 | 188 | 29 | $752 |
| Humira(Cf) Pen Adalimumab | 58 | 65 | Under 11 | $781K |
| Omeprazole Generic | 54 | 148 | 23 | $649 |
| Entyvio Vedolizumab | 51 | 72 | Under 11 | $436K |
| Mesalamine Generic | 45 | 109 | 15 | $29K |
| Famotidine Generic | 42 | 70 | 16 | $271 |
| Linzess Linaclotide | 39 | 63 | 14 | $36K |
| Promethazine Hcl Generic | 38 | 39 | Under 11 | $409 |
| Ondansetron Hcl Generic | 25 | 25 | 15 | $154 |
| Sodium Chloride 0.9 % Sodium Chloride | 22 | 31 | Under 11 | $106 |
| Azathioprine Generic | 21 | 37 | Under 11 | $540 |
| Budesonide Er Budesonide | 19 | 19 | Under 11 | $17K |
Brand drugs: 497 claims; generic drugs: 680 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura E Pontes $5,966 ($5,966 in general payments such as food, travel and fees) from 11 companies. The largest payer was Lilly USA, LLC with $2,898.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 8 | $2,898 |
| Janssen Biotech, Inc. JNJ | 12 | $1,570 |
| Abbvie Inc. ABBV | 29 | $682 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 14 | $305 |
| Pfizer Inc. PFE | 2 | $216 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $141 |
| Ardelyx, Inc. ARDX | 2 | $54.49 |
| Madrigal Pharmaceuticals MDGL | 1 | $27.83 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $25.66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $22.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.